Aigen Investment Management’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
6,211
+3,797
+157% +$648K 0.29% 100
2025
Q4
$341K Sell
2,414
-3,406
-59% -$387K 0.08% 327
2025
Q3
$472K Sell
5,820
-5,653
-49% -$436K 0.07% 411
2025
Q2
$719K Sell
11,473
-13,459
-54% -$796K 0.1% 314
2025
Q1
$1.8M Buy
24,932
+19,477
+357% +$1.58M 0.29% 92
2024
Q4
$470K Buy
5,455
+1,849
+51% +$184K 0.08% 348
2024
Q3
$342K Buy
+3,606
New +$320K 0.07% 427
2023
Q2
Sell
-21,579
Closed -$4.77M 725
2023
Q1
$4.77M Sell
21,579
-16,341
-43% -$4.03M 0.66% 37
2022
Q4
$8.22M Buy
37,920
+23,448
+162% +$6.25M 1.16% 11
2022
Q3
$3.83M Buy
14,472
+6,460
+81% +$1.64M 0.55% 46
2022
Q2
$1.67M Buy
+8,012
New +$1.79M 0.28% 100
2022
Q1
Sell
-5,504
Closed -$1.33M 529
2021
Q4
$1.33M Buy
+5,504
New +$1.36M 0.08% 327
2021
Q2
Sell
-2,845
Closed -$416K 442
2021
Q1
$416K Buy
+2,845
New +$457K 0.06% 331

Other funds holding ALB

Aigen Investment Management's ALB Position: Q1 2026 in Review

Aigen Investment Management increased its Albemarle (ALB) stake by 157% in Q1 2026, buying an estimated $648K and bringing the position to 6,211 shares worth $1.12M. The position accounts for 0.29% of the portfolio, ranked #100.

Aigen Investment Management first reported a position in ALB in Q1 2021 and has held it in 13 quarters since. The position peaked at $8.22M in Q4 2022. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Aigen Investment Management held 6,211 shares of Albemarle worth $1.12M as of Q1 2026.
  • Aigen Investment Management bought 3,797 Albemarle shares in Q1 2026, an estimated $648K.
  • Albemarle made up 0.29% of Aigen Investment Management's portfolio in Q1 2026, its #100 holding.
  • Aigen Investment Management first reported a position in Albemarle in Q1 2021 and has held it in 13 quarters since.
  • Aigen Investment Management's Albemarle position peaked at $8.22M in Q4 2022.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.